SCHEMBL25901097

SCHEMBL25901097

CCCCCCn1cnc2cc(-c3ncc(C(F)(F)F)cn3)c(F)cc2c1=O

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ DRD2 P14416 1/20 0.39
▸ DRD5 P21918 1/20 0.39
▸ DRD3 P35462 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ TNF P01375 3/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ DDR1 Q08345 6/20 0.38
▸ HTR7 P34969 1/20 0.37
▸ CNR2 P34972 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25898836 0.86 DDR1 (0.42) NPC1RAB9ASMN1; SMN2L3MBTL1DRD2
SCHEMBL26796485 0.86 NPC1 (0.40) NPC1RAB9ASMN1; SMN2L3MBTL1DRD2
SCHEMBL25908034 0.86 DRD2 (0.40) DRD2DRD5DRD3TNFDDR1
SCHEMBL26796438 0.85 TIPARP (0.45) NPC1RAB9ASMN1; SMN2L3MBTL1CYP1A2
SCHEMBL25899259 0.84 NPC1 (0.42) NPC1RAB9ASMN1; SMN2L3MBTL1CYP1A2
SCHEMBL25899268 0.84 NPC1 (0.41) NPC1RAB9ASMN1; SMN2L3MBTL1CYP1A2
SCHEMBL25898542 0.83 TIPARP (0.48) NPC1RAB9ASMN1; SMN2L3MBTL1TNF
SCHEMBL25900028 0.82 TIPARP (0.37) NPC1RAB9ASMN1; SMN2L3MBTL1CYP1A2
SCHEMBL25897832 0.82 TIPARP (0.49) NPC1RAB9ASMN1; SMN2L3MBTL1TNF
SCHEMBL25907905 0.82 ACHE (0.39) DRD2DRD5DRD3DDR1HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023147418-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. (US) 2023-08-03 — — WO disclosed
Send feedback